Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

11 Oct 2013 17:12

RNS Number : 3682Q
Maven Income and Growth VCT 5 PLC
11 October 2013
 



Maven Income and Growth VCT 5 PLC (the Company)

 

Interim Management Statement - quarter ended 31 August 2013

 

This Interim Management Statement, for the quarter ended 31 August 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 September 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 34.93p per share at 31 August 2013, after payment of the interim dividend, compared to 34.67p per share at 31 May 2013;

· NAV total return2 of 60.23p at 31 August 2013, compared to 59.32p at 31 May 2013; and

· Interim dividend of 0.65p per share in respect of the year ending 30 November 2013, paid on 30 August 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 August 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 August 2013, a net amount of £2,042,422 was invested in seven unlisted companies. In the same period, proceeds of £2,699,826 were realised from the sale of short-dated UK treasury bills; and the full or partial disposals of three AIM quoted investments generated aggregate proceeds of £194,874 against a total cost of £79,625.

 

3.

Recent developments

 

Between 1 September 2013 and the date of this Statement, £1,798,697 was invested in short-dated UK treasury bills; and the full or partial disposals of eleven AIM quoted investments generated proceeds of £ 1,400,754 against a cost of £ 1,023,854.

 

4.

NAV disclosure and Offer for Subscription

 

The NAV as at close of business on 10 October 2013 was 36.37p per share and reflects the closing bid price of quoted securities at that date. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2013, adjusted for subsequent events where appropriate.

 

As announced on 25 September 2013, the Company intends to raise up to £3 million by way of a joint Offer for Subscription alongside the other venture capital trusts managed by Maven Capital Partners UK LLP. It is intended that the NAV per share as at 10 October 2013 will be used as the basis for the subscription price for the new shares, subject to there being no material movement in the underlying net asset value. The NAV per share of the Company has, to date, been released on a daily basis. With immediate effect it is intended that, other than in exceptional circumstances, the Company will release NAV figures on a quarterly basis through annual and interim results announcements and interim management statements.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 June 2013 to 31 August 2013, or in the period from 1 September 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

11 October 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQFLFFXBFFFBF
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.